BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lohasz C, Bonanini F, Hoelting L, Renggli K, Frey O, Hierlemann A. Predicting Metabolism-Related Drug-Drug Interactions Using a Microphysiological Multitissue System. Adv Biosyst 2020;4:e2000079. [PMID: 33073544 DOI: 10.1002/adbi.202000079] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Gökçe F, Kaestli A, Lohasz C, de Geus M, Kaltenbach HM, Renggli K, Bornhauser B, Hierlemann A, Modena M. Microphysiological Drug-Testing Platform for Identifying Responses to Prodrug Treatment in Primary Leukemia. Adv Healthc Mater 2023;:e2202506. [PMID: 36651229 DOI: 10.1002/adhm.202202506] [Reference Citation Analysis]
2 Gabriele Specioso, David Bovard, Filippo Zanetti, Fabio Maranzano, Céline Merg, Antonin Sandoz, Bjoern Titz, Federico Dalcanale, Julia Hoeng, Kasper Renggli, Laura Suter-Dick. Apical Medium Flow Influences the Morphology and Physiology of Human Proximal Tubular Cells in a Microphysiological System. Bioengineering (Basel) 2022;9:516. [PMID: 36290484 DOI: 10.3390/bioengineering9100516] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Yan J, Li Z, Guo J, Liu S, Guo J. Organ-on-a-chip: A new tool for in vitro research. Biosens Bioelectron 2022;216:114626. [PMID: 35969963 DOI: 10.1016/j.bios.2022.114626] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Cox B, Barton P, Class R, Coxhead H, Delatour C, Gillent E, Henshall J, Isin EM, King L, Valentin J. Setup of human liver-chips integrating 3D models, microwells and a standardized microfluidic platform as proof-of-concept study to support drug evaluation. Biomaterials and Biosystems 2022. [DOI: 10.1016/j.bbiosy.2022.100054] [Reference Citation Analysis]
5 Gökçe F, Kaestli A, Lohasz C, de Geus M, Renggli K, Bornhauser B, Hierlemann A, Modena M. Microphysiological Drug-Testing Platform For Identifying Responses To Prodrug Treatment In Primary Leukemia.. [DOI: 10.1101/2022.04.06.483760] [Reference Citation Analysis]
6 Lohasz C, Loretan J, Sterker D, Görlach E, Renggli K, Argast P, Frey O, Wiesmann M, Wartmann M, Rausch M, Hierlemann A. A Microphysiological Cell-Culturing System for Pharmacokinetic Drug Exposure and High-Resolution Imaging of Arrays of 3D Microtissues. Front Pharmacol 2021;12:785851. [PMID: 35342386 DOI: 10.3389/fphar.2021.785851] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Hu W, Lettiere D, Tse S, Johnson TR, Biddle KE, Thibault S, Palazzi X, Chen J, Pithavala YK, Finkelstein M. Liver Toxicity Observed With Lorlatinib When Combined With Strong CYP3A Inducers: Evaluation of Cynomolgus Monkey as a Nonclinical Model for Assessing the Mechanism of Combinational Toxicity. Toxicol Sci 2021;182:183-94. [PMID: 34021354 DOI: 10.1093/toxsci/kfab056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Van Ness KP, Cesar F, Yeung CK, Himmelfarb J, Kelly EJ. Microphysiological systems in adsorption, distribution, metabolism, and elimination sciences. Clin Transl Sci 2021. [PMID: 34378335 DOI: 10.1111/cts.13132] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
9 Kulsharova G, Kurmangaliyeva A. Liver microphysiological platforms for drug metabolism applications. Cell Prolif 2021;:e13099. [PMID: 34291515 DOI: 10.1111/cpr.13099] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
10 Song K, Zu X, Du Z, Hu Z, Wang J, Li J. Diversity Models and Applications of 3D Breast Tumor-on-a-Chip. Micromachines (Basel) 2021;12:814. [PMID: 34357224 DOI: 10.3390/mi12070814] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]